HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.

Abstract
Caeruloplasmin has been determined immunologically and by coper oxidase activity in 25 normal subjects, 20 patients with Wilson's disease, and 80 patients with chronic liver disease. Repeated estimation in four patients with Wilson's disease and two heterozygous mothers from two families revealed a consistent reduction in the copper oxidase activity of caeruloplasmin (12-32 units copper oxidase activity/mg caeruloplasmin) relative to the values obtained in normal subjects, patients with chronic liver disease, and other Wilson's disease patients (mean 65-79 units/mg). It is suggested that the functional abnormality in caeruloplasmin observed in these two families is an inherited variant, which does not appear to be due to the presence of a serum inhibitor of copper oxidase.
AuthorsJ L Gollan, J Stocks, T L Dormandy, S Sherlock
JournalJournal of clinical pathology (J Clin Pathol) Vol. 30 Issue 1 Pg. 81-3 (Jan 1977) ISSN: 0021-9746 [Print] England
PMID838874 (Publication Type: Journal Article)
Chemical References
  • Copper
  • Oxidoreductases
  • Ceruloplasmin
Topics
  • Adolescent
  • Adult
  • Ceruloplasmin (metabolism)
  • Child
  • Child, Preschool
  • Copper
  • Female
  • Hepatolenticular Degeneration (blood, genetics)
  • Heterozygote
  • Humans
  • Liver Diseases (metabolism)
  • Male
  • Middle Aged
  • Oxidoreductases (metabolism)
  • Pedigree

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: